Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase EARLY_PHASE1 2Phase NA 1Phase 4 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 85Glioblastoma 82Pancreatic Neoplasms 75Glioma 65Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Melanoma 54Colorectal Neoplasms 54Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 50Squamous Cell Carcinoma of Head and Neck 46Recurrence 46Ovarian Neoplasms 45Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Sarcoma 35Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 33Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Interventions

corticorelin ovine 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Interventional × Pituitary ACTH Hypersecretion × Clear all
NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Mayo Clinic

Phase EARLY_PHASE1 Not yet recruiting
50 enrolled
Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT01459237 2018-06-14

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Completed
30 enrolled
Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡